AI-Focused Drug Discovery Stocks Portfolio Down 2% In May; Up 4% Last Week

The global "AI in drug discovery" market was worth $1.1B last year and is expected to expand by a CAGR of 30% between now and 2030 leading to 50 novel therapies over the next decade, with annual sales in excess of $50 billion
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.